Iron, hepcidin and the metal connection.
Identification of new players in iron metabolism, such as hepcidin, which regulates ferroportin and divalent metal transporter 1 expression, has improved our knowledge of iron metabolism and iron-related diseases. However, from both experimental data and clinical findings, iron-related proteins appe...
Main Authors: | Olivier eLoréal, Thibault eCavey, Edouard eBardou-Jacquet, Pascal eGuggenbuhl, Martine eRopert, Pierre eBrissot |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00128/full |
Similar Items
-
Iron as a Therapeutic Target in <i>HFE</i>-Related Hemochromatosis: Usual and Novel Aspects
by: Olivier Loréal, et al.
Published: (2018-11-01) -
Clinical management of hemochromatosis: current perspectives
by: Brissot P, et al.
Published: (2017-03-01) -
What’s Important and New in Hemochromatosis?
by: Pierre Brissot, et al.
Published: (2020-08-01) -
Management of liver complications in haemoglobinopathies
by: Pierre Brissot, et al.
Published: (2014-12-01) -
Surcharges en fer rares d’origine génétique : caractérisation clinique, fonctionnelle, et biologique
by: Bardou-Jacquet, Édouard
Published: (2013)